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Abstract
Background: Initial specification of cardiomyocytes in the mouse results from interactions between the extraembryonic
anterior visceral endoderm (AVE) and the nascent mesoderm. However the mechanism by which AVE activates
cardiogenesis is not well understood, and the identity of specific cardiogenic factors in the endoderm remains elusive. Most
mammalian studies of the cardiogenic potential of the endoderm have relied on the use of cell lines that are similar to the
heart-inducing AVE. These include the embryonal-carcinoma-derived cell lines, END2 and PYS2. The recent development of
protocols to isolate eXtraembryonic ENdoderm (XEN) stem cells, representing the extraembryonic endoderm lineage, from
blastocyst stage mouse embryos offers new tools for the genetic dissection of cardiogenesis.
Methodology/Principal Findings: Here, we demonstrate that XEN cell-conditioned media (CM) enhances cardiogenesis
during Embryoid Body (EB) differentiation of mouse embryonic stem (ES) cells in a manner comparable to PYS2-CM and
END2-CM. Addition of CM from each of these three cell lines enhanced the percentage of EBs that formed beating areas, but
ultimately, only XEN-CM and PYS2-CM increased the total number of cardiomyocytes that formed. Furthermore, our
observations revealed that both contact-independent and contact-dependent factors are required to mediate the full
cardiogenic potential of the endoderm. Finally, we used gene array comparison to identify factors in these cell lines that
could mediate their cardiogenic potential.
Conclusions/Significance: These studies represent the first step in the use of XEN cells as a molecular genetic tool to study
cardiomyocyte differentiation. Not only are XEN cells functionally similar to the heart-inducing AVE, but also can be used for
the genetic dissection of the cardiogenic potential of AVE, since they can be isolated from both wild type and mutant
blastocysts. These studies further demonstrate the importance of both contact-dependent and contact-independent factors
in cardiogenesis and identify potential heart-inducing proteins in the endoderm.
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Introduction
Studies in amphibians, avians and mice demonstrate that signals
from both the dorsal midline [1,2] and the endoderm
[1,3,4,5,6,7,8,9,10] are essential for the initial specification of the
cardiac mesoderm. However, experiments in which cells from the
undifferentiated mouse epiblast were transplanted directly to the
mesoderm (without traversing the primitive streak) demonstrated
that midline signals are not strictly required for cells to adopt a
cardiac fate [11]. This finding is consistent with our previous
observations that signals from the dorsal lip of the frog activate
heart formation indirectly by patterning the early endoderm
[12,13,14]. Therefore, while signals from the dorsal midline are
important for myocardial specification, it appears that the most
proximate signal in this process comes from the endoderm.
In the mouse, both the AVE and AVE-like cell lines have been
shown to direct nascent mesoderm toward cardiac fates [8,15].
In addition, the AVE also plays an important role in patterning
the anterior nervous system (reviewed in: [16,17]). Mouse ES
cells are pluripotent and, when grown as EBs, autonomously
differentiate into cell types derived from all three of the three
germ layers of the embryo, including rhythmically contracting
cardiomyocytes [18,19,20,21]. It is widely assumed that the
ability of EBs to spontaneously form beating cardiomyocytes
arises as a consequence of AVE formation within the EB, and
indeed, endodermal signals enhance myocardial differentiation
in both human and mouse EBs. Notably, the VE-like cell lines
END2 [15,22,23,24] and parietal endoderm-like PYS2 [25]
mimic this effect. More recently, it has been shown that the
AVE, and not the anterior definitive endoderm (ADE), induced
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ability [26].
Despite this growing body of work, the molecular nature of the
heart-inducing signal in the AVE has yet to be identified.
Moreover, it is not clear if the cardiogenic potential of the
endoderm results from the activity of a secreted factor or through a
contact-dependent effect of the endoderm. In addition, since both
END2 and PYS2 cell lines were initially derived from embryonal
carcinomas, it calls into question whether the cardiac-inducing
signal(s) from these cells truly represent the endogenous heart-
inducing signals in the embryo. The recent development of
protocols to isolate XEN stem cells [27] represents a promising
new approach that may overcome these difficulties. XEN cells are
derived from blastocyst stage mouse embryos and represent the
extraembryonic endoderm lineage: this being primitive endoderm
in the blastocyst and parietal and visceral endoderm at early
postimplantation stages. The visceral endoderm (VE) that overlies
the anterior part of the epiblast is believed to be the source of
cardiogenic inducing factors. We reasoned that since XEN cells
are molecularly similar to the heart-inducing anterior AVE
[27,28,29], they themselves might possess the ability to activate
heart formation. In addition, since they can be derived directly
from mouse embryos, the potential exists to isolate genetically
modified XEN cells, for example from mutant strains of mice. In
this way, mutant XEN cells can be used for a molecular dissection
of the ability of extraembryonic endoderm to induce and pattern
the heart.
Here, we compare the heart-inducing ability of XEN cells to
that of END2 and PYS2 cells, whose heart inducing ability has
been well-characterized (END2: [15,22,23,24]; PYS2: [25]). We
show that XEN cells, like END2 and PYS2 cells increase the
likelihood that a region of beating cardiomyocytes will form within
an EB and that both XEN and PYS2 cells increase the total
number of cardiomyocytes that form during EB differentiation,
suggesting that these cells not only activate the early steps of heart
formation, but also produce factors involved in either the survival
or proliferation of cardiomyocytes. In addition, all three cell lines
increase cardiac marker expression, but with different temporal
dynamics. Finally, comparative gene array analysis of these cell
lines offers the first step in identifying factors that mediate specific
steps of the cardiac specification program.
Results
XEN cells produce factors that increase myocardial
differentiation
XEN cells, like END2 and PYS2 cells, express markers for the
AVE [27,28,29], which has been proposed to be the heart-
inducing endoderm tissue in the mouse embryo [8,15]. Prompted
by these observations, we sought to determine whether XEN cells
can enhance myocardial differentiation from ES cells as has been
shown for other extraembryonic endodermal cell lines.
Studies in avian and amphibian embryos suggest that
endodermal signals are required only transiently during gastrula-
tion to direct mesoderm towards heart formation [1]. Given this
observation, we sought to investigate the temporal dynamics of
mesoderm formation in EBs. As a marker of gastrulation we used
T/Brachyury, which is expressed by the primitive streak and nascent
mesoderm of the mouse embryo. We analyzed Brachyury expression
in our cultures by qRT-PCR and determined that Brachyury
expression is initiated approximately 3 days after EB formation,
peaks at day 5, and is extinguished by day 7 (Figure 1A). We
hypothesized, based on analogy to studies in other vertebrate
organisms, that endodermal signals might preferentially exert an
effect during the early phases of mesoderm formation. In addition,
we were concerned that continuous addition of endodermally
conditioned media might enhance myocardial differentiation by
simply providing a nutrient rich environment that supports growth
and survival. For this reason, in this assay, endodermally
conditioned media was added to EBs only during this critical
early phase of mesoderm formation (EB days 4–6) (Figure 1B) with
treatment ending before the onset of beating.
Mouse embryonic stem (ES) cells possessing a transgene that
drives green fluorescent protein (GFP) under the regulation of the
MHCa promoter (MHCa::GFP) [30], a reporter of cardiomyo-
cytes, were differentiated as EBs using standard serum-containing
media. Under these conditions, expression of the MHCa::GFP
reporter was first initiated at around day 6 of EB differentiation,
the same time that cells within the EB began to beat rhythmically.
All rhythmically contracting cells expressed the MHCa::GFP
reporter (Movie S1). Conditioned media (CM) from END2, PYS2
and XEN cell lines were added, on days 4–6 (Figure 1A, B) (during
peak mesoderm formation). From day 6 (first day of beating) until
day 21, EBs were scored daily for beating and expression of the
GFP reporter (Movie S2). Approximately 50 EBs were scored each
day and beating was represented as a percentage of all EBs scored
(Figure 1C: line graphs), demonstrating the overall trend in
beating within the cultures. In control cultures, the percentage of
EBs with beating areas peaks on day 16 with approximately 60%
of EBs beating, whereas treatment with CMs increased this
percentage to approximately 75%, 79% and 80% for END2,
PYS2 and XEN-CM, respectively. To quantify this increase,
beating was also normalized to beating in media controls. To do
this the percentage of beating in treated cultures was represented
on each day as a percentage of the beating found in the control
cultures on the same day (Figure 1D: bar graphs). Addition of each
of the three CMs resulted in a greater percentage of EBs that
formed beating areas from day 10 onward.
We noted that while all three CMs increased the percentage of
EBs that formed beating areas, beating areas remained relatively
small in response to END2-CM. In contrast addition of PYS2-CM
and XEN-CM increased both the number and size of the beating
areas (Compare the difference Figure 2A and 2B to the differences
between Figure 2C to 2 D, E). To further assess this effect, we
performed flow cytometry on cells isolated from day 10 and day 13
EBs using the MHCa::GFP reporter to identify cells possessing a
cardiac fate (Figure 2F). GFP-positive cells were analyzed and
assessed as a percentage of total cells counted. Consistent with our
data showing an increase in the number of EBs that beat, addition
of XEN-CM or PYS2-CM from days 4–6 increased the
percentage of GFP-positive cardiomyocytes on day 10. However
by day 13, only EBs treated with XEN-CM continued to show a
statistically significant increase in the number of cardiomyocytes.
By contrast, treatment of EBs with END2-CM had no effect on
the number of GFP-positive cells present at day 10 or day 13.
Thus, while END2-CM increased the likelihood that an EB would
form beating areas, it appeared that either cardiac progenitors did
not expand after addition of END2-CM or that they failed to
further supplement endogenous cardiogenic signals that arose
from visceral endoderm formed by the EB. This finding was
consistent with previous data demonstrating that CM from END2
cells increased cardiac differentiation of human ES cells [22,23]
but that co-culture was required to enhance cardiac differentiation
from mouse ES cells [31].
To further assess the effect that these CMs have on cardiac
progenitors, we investigated the expression of a panel of cardiac
progenitor markers at day 7 (the second day at which beating was
observed in our cultures and one day after termination of
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factors (Tbx5, Nkx2.5 and Mesp1), which mark cardiac precursors,
and cardiac contractile proteins (MHCa, and MHCb). At day 7 of
differentiation, EBs treated from days 4–6 with PYS2-CM or
XEN-CM, but not those treated with END2-CM, exhibited
increased expression of MHCaand the cardiac transcription factor
Tbx5 (Figure 2G). Nkx2.5 and MHCb were also upregulated by
PYS2-CM but with low statistical probability (p-value=0.21 and
0.08 respectively). Mesp1 [32] was downregulated in response to
XEN-CM and PYS2-CM. After addition of END2-CM, cardiac
markers were either downregulated or unaffected on day 7. This
suggests that PYS2-CM and XEN-CM, but not END2-CM,
expand the size of the cardiac progenitor pool present in EBs.
Our flow cytometry analysis of these cells was based on the
expression ofGFPdriven by the MHCa promoter. This cellline has
been previously described [30]; however, we wanted to confirm that
the GFP reporter faithfully reflected cardiomyocyte differentiation
and wanted to show that treatment with XEN-CM neither activates
a non-cardiac cell type expressing the MHCa::GFP reporter nor
increases the stability of GFP in cells that may have previously
expressed cardiac markers transiently, but no longer do so. To
addressthese possibilities, EBsthat had been treated with XEN-CM
were dissociated using the same protocol as was used for the flow
cytometry studies, and plated onto gelatin-coated chamber slides.
24 hours after plating, cells were observed by fluorescence
microscopy. At this point, GFP–positive cells were seen as
rhythmically contracting cells in these dissociated cultures. By
contrast, no contractions were observed in GFP-negative cells. Cells
were then fixed and processed by immunocytochemistry for
antibodies recognizing GFP and the cardiac-specific epitopes,
Troponin, Cardiac Actin and Cardiac-specific Myosin (MF20).
We noted that GFP-positive cells also expressed Troponin and
Cardiac Actin (Figure 3A, B). There was also coexpression between
these cardiac markers and cells recognized by the MF20 antibody,
which recognizes cardiac-specific myosin (Figure 3C, D). These
findings demonstrate that MHCa::GFP is a faithful reporter of
cardiac fates and the addition of XEN-CM does not activate non-
cardiac GFP or enhance the perdurance of GFP.
Figure 1. Addition of extraembryonic endoderm cell conditioned medium (CM) from day 4–6 of EB differentiation impacts whether
EBs will form beating areas. Summary of data on the percentage of EBs that form beating areas in response to addition of media conditioned by
END2, PYS2 and XEN cells. A. Treatment windows were determined by the expression of Brachyury in EBs as quantified by qRT-PCR. B. In these
experiments, EBs were formed using a hanging drop method, and CM were added from days 4–6, during the peak of mesoderm formation (A). C.
Data is represented as the average percentage of EBs within treated cultures that formed beating areas in response to addition of END2-CM (green),
PYS2-CM (yellow) and XEN-CM (red) as compared to control cultures (blue). Polynomial trend lines are added to reveal the overall trend in these
cultures. D. For a higher resolution view of the data, each experimental set (3–4 trials/condition) was normalized to controls (blue bars) for each day
during the differentiation. Beating for each treated culture is displayed on each day as a percentage of beating in controls. (* indicates p-value,0.05,
** indicates a p-value,0.001).
doi:10.1371/journal.pone.0013446.g001
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(Figure 4) and noted that only EBs treated with XEN-CM
continued to show statistically significant increases in the
expression of cardiac markers including, MHCa, Tbx5, cTnI,
cTnT, Tbx5, Mlc2a and Mlc1a, Mlc2v. While the expression of
regional-specific markers has not been rigorously assessed during
EB differentiation, we noted that most of the markers upregulated
show biased expression toward the atria or inflow tract of the
embryonic heart (MHCa, Mlc1a, Mlc2a, cTnI [33], Tbx5
[34,35]), whereas markers that are more strongly expressed in
the ventricles (Hand1 [36,37], Hand2 [37] and Irx4 [38]) were not
significantly altered as compared to controls. Expression of the
conduction system marker Connexin-40 (Cx40) [39], and the
secondary heart field marker, Islet1 [40] (data not shown) were
also not significantly different between treated EBs and controls.
Taken together these data suggest that factors in XEN-CM may
bias cardiomyocyte differentiation toward an atrial fate. To further
address this, we analyzed the expression of atrial specific markers
ANF/Nppa and Shox2, which mark the whole atrium and the right
atrial wall, respectively. Nppa was not significantly different
between treated and untreated EBs (not shown) and only PYS2-
CM treated EBs showed a statistically significant increase in Shox2
expression, which marks the sinus venosus, and later, the dorsal
wall of the right atrium [41]. Together, these findings suggest that
endodermal CMs do not affect the overall patterning of the
myocardium.
Finally, since addition of END2-CM only enhanced beating in
our cultures after day 13, we also assessed MHCa expression on
day 16. We found that even at this stage, MHCa expression was
enhanced by PYS2-CM and XEN-CM, but not by END2-CM
(data not shown). These findings demonstrate that although
addition of END2-CM affects the likelihood that an EB will form
rhythmically contracting cardiomyocytes, END2-CM either lacks
signals supporting the subsequent proliferation of cardiomyocytes
or causes a non-specific increase in proliferation of all cell types
within the EB, thereby masking any effect that it might have on
cardiomyocyte differentiation. To address this, we measured the
overall growth rate of EBs during and after treatment with
conditioned media by counting the total number of cells in 20 EBs
on each day of culture. We found no difference in the growth rate
Figure 2. Addition of XEN-CM and PYS2-CM, but not END2-CM increases the amount of cardiomyocytes that form in culture and
increases expression of cardiac markers as assessed by qRT-PCR. A, C. Merge of bright field and pseudo-colored fluorescence images to
show distribution of cardiomyocytes in control EBs. A separate control is included for END2 cells since they are grown in different medium from the
other two cell lines. B, D, E. Merge of bright field and pseudo-colored fluorescence images to show distribution of cardiomyocytes after treatment on
days 4–6 with (B) END2, (D) PYS2 and (E) XEN-CM. F. Summary of flow cytometry data showing the fold change in the number of MHCa::GFP (+) cells
on day 10 and 13 after addition of CM on days 4–6. (*indicates a p,0.05). G. qRT-PCR data showing expression of cardiac markers at day 7 after
treatment of EBs with CM on days 4–6. (* indicates p,0.05).
doi:10.1371/journal.pone.0013446.g002
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suggests that endodermally conditioned media may specifically
affect the proliferation or survival of differentiating cardiomyocytes
in EBs, but not the overall rate of cell division.
The cardiogenic activity of endodermal cells is sensitive
to timing
Studies of cardiac specification in various animal models reveal
a strict temporal requirement for signals from the endoderm
involved in this process [1,42]. To test this, EBs were treated with
CM in an earlier time window, between days 2–4, which
corresponds to a period just prior to mesoderm formation in our
cultures (Figure 5A, B). One possible mechanism by which
endodermal signals might enhance myocardial differentiation is by
increasing mesoderm formation. If this were the case then it might
be expected that addition of CMs at this earlier time point might
further increase cardiac differentiation. As before, we tested
whether addition of CM could increase the percentage of EBs that
formed beating areas. EBs were assessed from day 6 (first day of
beating) until day 21, for beating and activity of the MHCa::GFP
reporter. Approximately 50 EBs were scored each day, and
beating was represented as a percentage of all EBs scored
(Figure 5C: line graphs) to show the overall trend in beating
within the cultures. Beating was also normalized to controls and
represented on each day as a percentage of beating in controls on
that day (Figure 5D: bar graphs). In contrast to the results obtained
when CM was added during the peak of Brachyury expression,
when EBs were treated from day 2–4 (prior to mesoderm
formation) CM either had no effect on, or delayed the onset of
beating (Figure 5D). Only XEN-CM enhanced beating when
added in this time window. To confirm this, we performed flow
cytometry on cells isolated from day 10 EBs using MHCa::GFP
reporter for cells possessing a cardiac fate (Figure 6A–E). GFP-
positive cells were analyzed and assessed as a percentage of total
cells counted. Addition of endodermal-CM from days 2–4 had
either no impact or a negative impact on the percentage of GFP-
positive cells at day 10 as compared to controls (Figure 6F). This
was consistent with EB counting data on day 10. These cultures
were also analyzed by flow cytometry at day 13. There was a small
but statistically significant increase after treatment with PYS2-CM,
but otherwise there were no differences between treated and
untreated EBs at these time points (Figure 6F). As before, we also
assessed myocardial specification in response to endodermal CM
by using qRT-PCR to assess for changes in the expression of
mesoderm markers generally and cardiac markers specifically. At
day 4, (just after the termination of CM treatment) we examined
the expression of markers for the nascent mesoderm (Figure 6G).
None of the CMs increased expression of Brachyury, but addition of
XEN-CM in this time window did result in a statistically
significant increase of Fgf8 expression.
To assess the effect that this earlier treatment had on the
expression of cardiac progenitor markers, we examined the
expression of the cardiac contractile proteins MHCa and MHCb,
as well as the transcription factors Nkx2.5, Tbx5 and Mesp1
Figure 3. Immunocytochemistry of MHCa::GFP(+) cells induced by XEN-CM. EBs treated from days 4–6 with XEN-CM were dissociated as
described for flow cytometry analysis. They were then fixed and processed for immunoctyochemistry using antibodies that recognize either GFP
(green in A and B) or the cardiac specific epitopes Troponin (red in A and C), Cardiac Actin (red in B and D) and cardiac-specific Myosin (MF20) (green
in C and D). These studies demonstrate the correlation between cardiac markers and GFP.
doi:10.1371/journal.pone.0013446.g003
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CM exhibited decreased expression of MHCa and Tbx5 as
compared to controls. Other cardiac markers were unaffected in
response to END2-CM. By comparison, PYS2-CM and XEN-CM
resulted in a decrease in expression of Mesp1. In general, treatment
in this time window resulted in an overall decrease in the
expression of cardiac progenitor markers.
To test the effect of endodermally conditioned media on overall
cardiac differentiation, we also assessed a panel of cardiac markers
on day 10 of differentiation (Figure 7). Treatment of PYS2-CM or
XEN-CM on days 2-4 resulted in a downregulation of Mlc2a and
Hand2 at day 10, whereas other markers were not significantly
different from controls. Interestingly, EBs treated with END2-CM
on days 2–4 exhibited a general upregulation of cardiac marker
expression on day 10. This data does not correlate with either an
overall increase in the number of cardiomyocytes or an increase in
the percentage of EBs with beating areas. Indeed day 10
represented a low point in terms of percent beating as compared
to controls (Figure 5D), This finding tells us that mRNA expression
does not necessary correlate temporally with cardiac fate.
Therefore cardiac induction can only be assessed by a comparison
of molecular, functional and marker analysis at several time points,
such as we present here.
Microarray analysis
Our analyses not only demonstrate that XEN cells have cardiac
inducing ability but this also reveal differences between XEN cells
and other heart-inducing endodermal cell lines. We have
previously performed an extensive comparison of microarray data
from END2, PYS2 and XEN cells [28]. In this previous study, we
validated these arrays by demonstrating a high (greater than 80%)
correlation between array data and our other methods (for
example qPCR) of quantifying gene expression within these cells.
Prompted by our finding that XEN cells, like previously
characterized heart-inducing cells, have the ability to activate
heart formation, we re-analyzed these arrays. Specifically, we
sought [28] to identify secreted factors that might account for the
contact-independent ability of endodermal cell lines to support
myocardial differentiation. To accomplish this, we compared gene
rosters for ontology terms classified by the Gene Ontology (GO)
Consortium (http://www.geneontology.org) [43] as ‘‘cardiac
development’’, ‘‘extracellular space’’, and ‘‘receptor binding’’,
and identified a list of 11 common genes (Figure 8). Of these genes
only two, Endothelin1 and Tgfbeta2, were detected in the arrays, and
of these only Endothelin1 is expressed by all three heart-inducing
extraembryonic endoderm cell lines. This finding suggests that the
cardiogenic factors secreted by endodermal cell lines have yet to be
characterized and classified by GO.
To expand the list of candidate secreted factors that might
account for the cardiac inducing ability of these extraembryonic
endodermal cell lines, we analyzed the expression of the remaining
222 Venn-restricted genes. The largest group (comprising 28
genes) of the remaining Venn-restricted genes were members of
the TGFbeta superfamily of signaling molecules (Figure 9A). Of
these, the three extraembryonic endodermal cell lines expressed
only six genes, including TGFbeta-1 and -2. This finding is
consistent with our previous observation that all components of
known TGFbeta signaling pathways are present in these cell lines
[28]. Another 17 Venn-restricted terms comprised other growth
factors, of which 8 were expressed in at least one of the cell lines
(Figure 9B). While not included in the Venn-restricted data set, we
also assessed the presence of Wnt family members and BMP
Figure 4. Cardiac Marker expression on Day 10 following treatment on days 4–6. qRT-PCR data showing expression of a panel of general
and region-specific cardiac markers at day 10 after treatment of EBs with CM on days 4–6. (* indicates p,0.05).
doi:10.1371/journal.pone.0013446.g004
Cardiogenesis by XEN Cells
PLoS ONE | www.plosone.org 6 October 2010 | Volume 5 | Issue 10 | e13446antagonists (Figure 9C) since these signaling pathways have been
extensively implicated in the early phases of cardiac specification.
We found that all of the cell lines expressed the BMP antagonists
Follistatin and Noggin, but only three Wnt family members, Wnt11,
Wnt4 and Wnt7b were expressed. Finally, of the 175 remaining
Venn-restricted terms, 38 were expressed in at least one of the cell
lines (Figure 10). These data represent a comprehensive set of
secreted factors with known receptor binding activity that are
expressed in cells lines possessing heart inducing ability.
We observed marked differences between END2 cells and XEN
cells in terms of their effects on cardiac development. XEN-CM
was the only CM that enhanced beating when added prior to
mesoderm formation and was the only CM to maintain enhanced
expression of cardiac markers until day 10. By contrast, END2-
CM was the only CM to block, or delay, cardiomyocyte formation
when added prior to mesoderm formation. Because of this, we
performed further analysis to identify the genes that were most
upregulated in END2 cells as compared to PYS2 and XEN cell
lines (Table S1, END2 cells and Table S2, XEN cells). Top hits
were compared using the DAVID bioinformatics tool (http://
david.abcc.ncifcrf.gov/) [44,45] to determine molecular functions
or pathways unique to these cells that might account for their
distinct functions. Analysis of genes uniquely upregulated in XEN
cells revealed a number of factors known to be involved in heart
development (p-value 6.8E-4), calcium homeostasis (p-value 1.1E-
2) or ion transport (1E-1) (Table S2). In addition, pathway analysis
revealed that only XEN cells expressed the retinoic acid (RA)-
degrading enzyme Cyp26a1 [46,47,48].
VE formation on the surface of EBs may reveal a
requirement for contact-dependent signals from the
endoderm
Although addition of CM increases both the percentage of EBs
that formed beating areas and the percentage of MHCa expressing
cells in our culture system, it is equally clear that EBs
spontaneously form beating cardiomyocytes without the addition
of CM. Since mouse EBs generate a surface layer of extraembry-
onic endoderm, which resembles VE [49], we surmised that if EBs
Figure 5. Addition of extraembryonic endodermal conditioned medium (CM) from days 2–4 of EB differentiation either had no
impact on beating or delayed the formation of myocardial cells. Summary of data showing the effect of conditioned media on the
percentage of EBs that form beating areas in response to addition of media conditioned by END2, PYS2 and XEN cells. A. Treatment windows were
determined by the expression of Brachyury in EBs as determined by qRT-PCR. B. In these experiments EBs were formed using a hanging drop method,
and CM were added from days 2–4, prior to the onset of mesoderm formation (A). C. Data is represented as a percentage of EBs within treated
cultures that formed beating areas in response to addition of END2-CM (green), PYS2-CM (yellow) and XEN-CM (red) as compared to control cultures
(blue). Polynomial trend lines are added to reveal the overall trend in these cultures. D. For a higher resolution view of the data, each experimental
set (3–4 trials/condition) was normalized to controls (blue bars) for each day during the differentiation and beating is displayed on each day as a
percentage of beating in the control condition on that day. (* indicates p-value,0.05, ** indicates a p-value,0.001).
doi:10.1371/journal.pone.0013446.g005
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from CM treatment could be masked. Conversely, it is possible
that factors present in the CM simply supplement factors that are
already present in the EBs.
To address this question, we derived an ES cell line from a
strain of mice expressing GFP under the control of the Afp
promoter [50]. During early embryonic development, this
promoter drives GFP expression in the VE. If VE forms, then
we would expect to see GFP expressing cells at the surface of
differentiating EBs and, starting at day 3, we could visualize GFP-
positive cells on the surface of EBs. These cells eventually came to
occupy the entire surface of the EB (Figure 11A–J). Although we
also noted GFP-positive cells inside the EB at day 9, these internal
GFP-positive cells did not express Afp mRNA (compare Figure 11P
to Figure 11Q) and likely represented cells that had downregulated
Afp expression but remained GFP-positive due to perdurance of
the GFP protein.
We also analyzed the differentiating EBs for a panel of markers
expressed in the VE (Sox7, Ttr, Pdgfra and Gata6) and AVE (Cerl,
Hex and Dkk-1) of mouse embryos using qRT-PCR. We found that
these genes were transiently expressed, beginning at about day 3
and persisting throughout the course of the experiment
(Figure 11R). Three VE markers exhibited unique patterns of
expression that might indicate that they play specific roles in the
formation of the VE. Sox7 was expressed at high levels throughout,
while expression of Afp and Cerl began to increase a day earlier
than other markers. In addition, Cerl exhibited a significant
downregulation by day 7, not seen with the other markers
(Figure 11S). These data demonstrate that when EBs are
differentiated under optimal conditions for cardiomyocyte differ-
entiation they also make ample quantities of VE. Therefore, while
there are clearly contact-independent factors secreted by the VE
that enhance myocardial differentiation, our data cannot rule out
the possibility that there are additional contact-dependent effects
of VE as well.
Both contact-dependent and contact-independent
factors are likely to impact cardiomyocyte differentiation
in EBs
To address the possibility that VE formation within the EB may
mask the requirement for contact-dependent signals in cardiomy-
ocyte formation, we empirically determined conditions in which
Figure 6. Effect of CM on cardiomyocyte differentiation when added before mesoderm formation. A, C. Merge of bright field and
pseudo-colored fluorescence images to show distribution of cardiomyocytes in control EBs. A separate control is included for END2 cells since they
are grown in different medium from the other cell lines. B, D, E. Merge of bright field and pseudo-colored fluorescence images to show distribution
of cardiomyocytes after treatment on days 2–4 with (B) END2, (D) PYS2 and (E) XEN-CM. F. Summary of flow cytometry data showing the fold change
in the number of MHCa::GFP (+) cells on days 10 and 13 after addition of CM on days 2–4. (*indicates a p,0.05). G, H. qRT-PCR data showing
expression of mesoderm markers at days 4 and cardiac markers on day 7 after treatment of EBs with CM on days 2–4. (* indicates p,0.05).
doi:10.1371/journal.pone.0013446.g006
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size was decreased and serum was replaced with a defined serum
replacement. Under these conditions, we found that VE formation
began approximately 2 days later than in controls. In this
condition we also found that mesoderm formed robustly (as
assessed by the expression of Brachyury), but that cardiac
differentiation was severely impaired with only a small background
of cells expressing the MHCa::GFP reporter and beating (data not
shown). To test whether factors in the CM could rescue cardiac
differentiation, we added CMs (also produced in serum-free
media) at days 4–6 of EB differentiation (Figure 12B). At day 10
we analyzed the percentage of cells within the culture that
underwent myocardial differentiation and noted a 2–3 fold
increase in cardiomyocyte differentiation when EBs were treated
with CM as compared to EBs grown in the serum-free media
alone. However, the total number of myocardial cells that formed
remained lower than those that formed under standard, serum
containing, media conditions. This suggests that there are either
contact-dependent signals produced by the VE or that there are
factors in serum, but absent in serum-free media that are required
for expansion of cardiac progenitors that form within EBs.
Discussion
Identifying the heart inducing factors produced by the
AVE
Heart disease is a leading cause of death and decline among
adults in much of the developed world. In particular, ventricular
infarct is highly correlated with poor medical outcome. For this
reason, much effort has been directed toward the identification of
possible sources of donor myocardial cells that could be used to
repair damaged tissue. This might be accomplished either by the in
vitro differentiation of cardiomyocytes from stem cell sources or the
in vivo mobilization and directed differentiation of stem cells
resident in the heart or other adult tissues.
Efforts to differentiate cardiomyocytes in vitro have been
hampered by the observation that while mouse and some
human ES cells readily become cardiomyocytes when differen-
tiated in EBs, this ability to form cardiomyocytes varies between
cell lines. The reason for this is unclear, but our data suggest
that this could be due to visceral endoderm (VE) formation in
EBs. Here, we show that conditions promoting myocardial
differentiation also favor VE formation and that conditions that
delay or block VE formation also block heart formation. In
support of our observations, both human ES cells and mouse
epiblast stem cells (EpiSCs) display the propensity to form
cardiomyocytes, which correlates with a propensity to form
extraembryonic endoderm [51,52]. Further support for this idea
comes from a recently devised protocol in which the differen-
tiation of human ES cells toward cardiomyocyte lineages is
greatly enhanced as compared to untreated human ES cells.
[53]. In this protocol, EBs were treated with a cocktail of BMP
and Activin, the latter of which mimics the effects of Nodal. Six
days after treatment, a distinct KDR
lo/cKit
neg cell population,
can be isolated by FACS. This KDR
lo/cKit
neg population is
highly enriched for cardiac cells, as compared to the unsorted
ES cell pool [53]. While this study did not explicitly investigate
VE formation, previous studies suggest that Nodal acts
indirectly in heart formation by inducing VE and upregulating
markers specific for the heart-inducing anterior visceral
endoderm (AVE) [14].
If, as these data suggest, VE formation generally and AVE
formation specifically are required in human and mouse EBs for
myocardial differentiation, then understanding the signals that
regulate AVE formation and the specific signals within the AVE
that mediate heart formation will be critical to the development of
refined protocols for myocardial differentiation. Furthermore, the
identification of heart inducing factors secreted by VE-like cell
lines will be critical for the molecular identification of endogenous
cardiac inducing signals.
Figure 7. Cardiac marker expression on day 10 following treatment on days 2–4. qRT-PCR data showing expression of a panel of general
and regional specific cardiac markers at day 10 after treatment of EBs with CM on days 2–4. (* indicates p,0.05).
doi:10.1371/journal.pone.0013446.g007
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enhance myocardial differentiation
XEN cells are a recently reported stem cell type isolated from
blastocyst stage mouse embryos with the potential to differentiate
into extraembryonic endodermal derivatives [27]. This, in combi-
nation with the fact that they can be derived from mutant strains,
make them a potentially powerful tool both for the in vitro study of
VE differentiation and for the identification of cardiogenic factors
produced in the VE. Here we present the first functional
characterization of the ability of XEN cells to support myocardial
differentiation. We have also compared the gene expression profile
of XEN cells to that of other VE cell lines, which have previously
beenreported topromotecardiacdifferentiation[15,22,23,54].Our
data identify a discrete set of secreted factors that could account for
the ability of VE cell types to support myocardial differentiation.
The role of retinoic acid in heart formation
In these studies, only XEN-CM influenced whether or not an EB
formed a beating area when added prior to mesoderm formation.
The fact that XEN-CM affected the acquisition of beating, but did
not affect the subsequent differentiation or proliferation of
cardiomyocytes when added in this time window, suggests that
signals from XEN-CM affect a very early step in the cardiomyocyte
differentiation program. Indeed, when XEN-CM was added in this
early time window, we noted an increase in the expression of Fgf8,
which is required in the mouse for the establishment of cardiac
progenitors [55,56]. However, most cardiac markers remained
unchanged or were downregulated as compared to controls. One
factor that was differentially expressed by XEN cells, as compared
to the otherheartinducing extraembryonic endodermcell lines,was
the retinoic acid (RA) degrading enzyme Cyp26a1 [48,57,58],
thereby implicating RA signaling in this process.
A large body of data suggests that there is an antagonistic
relationship between RA and FGF signaling in the neural plate
[59,60], in the heart [61] and in the primitive streak/tail bud [62,63].
Notably, RA signaling has also been show to restrict the size of the
cardiac progenitor pool in zebrafish [64], and to block myocardial
differentiation in Xenopus [65]. The role of RA in activating heart
formation from mouse EBs is unclear, since both RA [66] and RA
antagonists [67] have been reported to increase myocardial
differentiation of ES cells. These differences could be related to
nuances in the protocols used or could reflect issues of cardiac
Figure 8. Growth factors secreted by heart inducing cell lines. Venn diagram showing overlapping transcripts among the Gene Ontology
(GO) Consortium classifications BP: cardiac development (GO term: 0007507), MF: receptor binding (GO term: 0005102) and CC: extracellular space
(GO term: 0005615). Eleven factors were found to be present in all three data sets and are represented as a heat map. Of these, only two factors,
Endothelin and TGFbeta2 were detected in the arrays (based on a p-value of detection less than 0.01). The data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus [73] and are accessible through GEO Series accession number GSE19564 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE1956.
doi:10.1371/journal.pone.0013446.g008
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differentiation. Nonetheless, our findings, together with these earlier
studies suggest that RA signaling is likely to play complex roles in the
induction and patterning of the myocardium.
Insight into the role of Cerberus in heart formation
One unexpected observation from the current study relates to the
expression and function of Cerl, a marker of the AVE in mouse
embryos. We had previously shown that activation of Cerberus in the
endoderm downstream of Nodal signaling is required for normal
cardiac induction and is sufficient to activate ectopic heart field
formation in Xenopus embryos [14]. Our present analysis of marker
expression in differentiating EBs suggests that Cerl is activated earlier
during EB differentiation than other VE markers (Figure 11S),
suggesting a possible functional role in establishing the AVE. Despite
the apparent importance of Cerl in heart induction, none of the heart
inducing cell lines express this marker (Figure 9C). Since active Cerl
expression is not required for the heart inducing ability of VE cell lines,
Cerl may act transiently in the VE to activate other AVE markers.
Contact-dependent and contact-independent roles for
endoderm
Our findings suggest that extraembryonic endodermal cell lines
express factors capable of initiating and/or enhancing myocardial
differentiation of mouse ES cells. The fact that this effect can be
mediated by conditioned media (CM), as opposed to co-culture,
suggests that the heart inducing effect of the VE is independent of
cell contact. On the other hand, our data demonstrate a similarly
important role for contact-dependent effects of endoderm in heart
formation. In culture conditions that delay VE formation we find
that heartinductionisgreatlyreduced andthat thisreductionis only
partially rescued by the addition of extraembryonic endodermal
CM. Thus, factors from CM may serve to supplement required
contact-dependent signals from the VE. Future studies aimed at
addressing this question will necessitate the generation of EBs
lacking VE or the conditional ablation of VE from established EBs.
Materials and methods
Ethics Statement
Since this work does not include human participants, these
studies do not require institutional review board approval. Animal
studies in which the Afp:GFP ES cell line was derived, were carried
out with IACUC approvals.
Cell Culture
Mouse Afp::GFP ES cells were derived from hemizygous
blastocysts possessing the Afp::GFP reporter as described in Kwon
Figure 9. Venn-restricted factors expressed by heart inducing cell lines. A. Expression of Venn-restricted TGFbeta family members in the
subset defined by GO terms [receptor binding] and [extracellular space]. Normalized array data are expressed as a heat map. B. Expression of Venn-
restricted growth factors in the array in the subset defined by GO terms [receptor binding] and [extracellular space]. C. Expression of BMP antagonists
and Wnt family members (not Venn-restricted) expressed in the array. Probes are called as present if the p-value for detection was less than 0.01.
doi:10.1371/journal.pone.0013446.g009
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PLoS ONE | www.plosone.org 11 October 2010 | Volume 5 | Issue 10 | e13446Figure 10. Additional extracellular factors identified by Gene Ontology are expressed by heart inducing cell lines. Normalized
expression in the array, expressed as a heat map, of the remaining 38 Venn-restricted factors that were detected as present in the array based on a
detection p-value,0.01.
doi:10.1371/journal.pone.0013446.g010
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PLoS ONE | www.plosone.org 12 October 2010 | Volume 5 | Issue 10 | e13446Figure 11. EBs form VE under conditions that promote cardiomyocyte differentiation. A–E. Cross-sections of EBs showing expression of the
Afp::GFP VE reporter as well as the endodermal marker SOX17 (purple). F–J. Whole mount expression of Afp::GFP in EBs over atime course. K–O. Whole mount
in situs of EBs showing expression of the endogenous Afp. P. Detail of Figure 11D. Q.D e t a i lo fF i g u r e1 1 N .R. Dynamic expression of early endoderm markers
(Gata6, Pdgfra, Ttr, Hex, Dkk-1, Bmp2) over a time course. S. Dynamic expression of early endoderm markers (Cerl, Afp, and Sox7) over a time-course.
doi:10.1371/journal.pone.0013446.g011
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CGR8-MHCa-IRES::GFP [30] and Afp::GFP ES cells were
maintained in ES cell growth medium comprising high glucose
Dulbecco’s Modified Eagles Medium (DMEM) (Mediatech)
supplementedwith10%ESqualifiedFetalBovineSerum(GIBCO),
non-essential amino acids (Mediatech), L-glutamine, sodium
pyruvate (Mediatech), LIF (Millipore), Penicillin/Streptomycin
(Mediatech) and b-mercaptoethanol (Sigma). XEN cells were
derived from ICR strain blastocyst stage embryos according to
standard procedures [27]. END2 cells were derived from P19
embryonal carcinoma cell lines [69] and PYS2 cells were derived
from 129 strain mice tumor cells [70]. XEN and PYS2 cells were
both maintained in ES medium without LIF. END2 cells were
grown in DMEM/F12 1:1 media (Mediatech) supplemented with
10% FBS, L-glutamine, non-essential amino acids and Penicillin/
Streptomycin (Mediatech). Media conditioned by 24-hour incuba-
tions with each of the three cell lines (XEN, PYS2 or END2) were
collected, sterile filtered and stored at 220uC. These CMs are
referred to as XEN-CM, PYS2-CM and END2-CM, respectively.
EB Differentiation
CGR8-MHCa-IRES::GFP and Afp::GFP ES cells were differen-
tiated in standard differentiation medium, which is comprised of
Iscove’s Modified Dulbecco’s Medium (IMDM) (Gibco), supple-
mented with 10% differentiation grade FBS (Gibco), 0.5 mM
ascorbic acid, 4.561024 M monothioglycerol (Sigma), 5%
protein-free Hybridoma Media (PFHM-II) (Gibco), 200 mg/mL
apo-Transferrin (Sigma) and Penicillin/Streptomycin (100 units/
mL and 100 mg/mL, respectively) (Mediatech). EBs were formed
in 20 mL hanging drops (each comprising 300 cells) and incubated
at 37uC for 24 hours. EBs were then washed into Petri dishes
(Fisher) or re-plated onto 0.1% gelatin coated tissue culture dishes.
For differentiation in the absence of FBS, serum-free differenti-
ation medium was made with KnockoutH DMEM (Gibco). This
medium was supplemented with 20% Knockout Serum Replace-
ment (Gibco), 16 non-essential amino acids (Mediatech), 16 L-
glutamine (Mediatech), 0.1mM b-mercaptoethanol (Sigma), 9.6 ml
7.5% sodium bicarbonate, and 6ml nucleotide solution. Nucleotide
solution was reconstituted as follows: 80mg adenosine, 73mg
cytodine, 85 mg guanine, 73mg uridine, and 24mg thymidine (all
from Sigma) per 100mL of cell culture grade water [71].
At the onset of serum-free differentiation, EBs were made in
standard differentiation medium (with FBS) as previously de-
scribed. Importantly, however, 20ml hanging drops were made
with 100 cells (i.e. 100 cells/EB) instead of 300cells/EB. EBs were
then washed into serum-free differentiation medium on day 2 of
differentiation, and media was changed every 2 days.
Real Time PCR
EBs were collected on specific days of differentiation, RNA was
isolated using Tri Reagent (Sigma), and cDNA was transcribed
using Quantitect Reverse Transcription Kit (Qiagen). qRT-PCR
Figure 12. Culture conditions that delay VE formation also block cardiac differentiation, but cardiac differentiation is partially
rescued by the addition of endodermally conditioned medium. A. Pseudo-colored fluorescence images showing Afp::GFP expression (Green)
during EB formation under normal serum-containing conditions (STD) and during serum-free conditions (SRM). Note that VE formation is delayed by
approximately 2 days. B. Summary of Flow Cytometry data for MHCa::GFP at day 10 comparing EBs grown under standard condition to those grown
under serum free conditions. Addition of all three endodermally conditioned media, but not MEF conditioned medium, had a positive impact on
cardiomyocyte formation.
doi:10.1371/journal.pone.0013446.g012
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SybrGreen Master Mix (Roche, cat #: 04707516001), on a Roche
LightCycler H 480 Real-Time PCR Instrument, and analyzed with
the LightCycler 480 software package (version 1.5.0.39). Crossing
point data were first adjusted to reflect the efficiency of primer
pairs by comparison to standard curves, (based on dilution series
over a total dynamic range of 1:1,000 or 1:10,000 for positive
control cDNAs). These data were then normalized to the
ubiquitously expressed mRNA Gapdh. Finally, data were re-
normalized to untreated controls. Significance was determined by
comparison of treated and untreated samples by t-test. Changes
were considered significant if the p-value was less than 0.05. In all
graphs, error bars reflect standard error calculated from 3–4
separate trials.
The primers used in this study are as follows:
Alpha-fetoprotein (Afp): forward AGCTGACAACAAGG GGA-
GTG, reverse TTAATAATGGTTGTTGCCTGGA; Brachyury:
forward AGCTTCGTGACGGCTGACAA, reverse CGAGT-
CTGGGTGGATGTAG; Cerberus-like (Cerl): forward GCAGACC-
TATGTGTGGA, reverse ATGAGACATGATCGCTTT; Bmp2:
forward TGTGGGCCCTCATAAAGAAGC, reverse AGGGTG-
CAGGCAGGAAACATA; Dkk-1:f o r w a r dTACAATGATGGCT-
CTCTGCAGCCT, reverse TGGTCAGAGGGCATGCATATT-
CCA;F g f 8 : forward GCTCATTGTGGAGACCGATAC, reverse
TTGCTCTTGGCAATTAGCTTC;F o x a 2 : forward CGGCC-
AGCGAGTTAAAGTAT, reverse TCATGTTGCTCACGGAA-
GAG;G a p d h : forward AATGGATACGGCTACAGC, reverse
GTGCAGCGAACTTTATTG; Gata4: forward CATCAAATCG-
CAGCCT, reverse AAGCAAGCTAGAGTCCT; Gata6:f o r w a r d
CGGGCGCAGGCAGTGTGAGT, reverse CCAAGCCGCCG-
TGATGAAGG; Hex: forward GGAGGCTGATCTTGACT, re-
verse GTAGGGACTGCGTCAT; Islet 1 (Isl1): forward GAGT-
CATCCGAGTGTGGTTTC, reverse ACCATGGGAGTTCCT-
GTCATC; Mesp-1: forward AATGCAACGGATGATTGT, re-
verse AGCGTGTACCCTATTGG; Myosin Heavy Chain-alpha
(MHCa): forward CATGCCAATGACGACCT, reverse CCTA-
CACTCCTGTACTGCC; Myosin Heavy Chain-beta (MHCb): for-
ward GGTGGCAAAGTCACTGCTGA, reverse ACAGGCAGC-
CACTTGTAGGG;N k x 2 . 5 : forward TTACCGGGAGCCTA-
CGGTG, reverse GCTTTCCGTCGCCGCCGTGCGCGTG;
Nppa: forward GTGGGCAGAGACAGCAAACA, reverse TCTG-
TGTTGGACACCGCACT; Shox2: forward TCCCCTGAACT-
GAAGGATCG, reverse CAGTCGCTGGCTCAATTCCT Tbx5:
forward CCAGCTCGGCGAAGGGATGTTT, reverse CCGAC-
GCCGTGTACCGAGTGAT; cardiac Troponin I (cTnI): forward
CCGCCTCCAGAAAACTTCAG, reverse CGTGAAGCTGTC-
GGCATAAG; cardiac Troponin T (cTnT): forward GAGGTGGTG-
GAGGAGTACGA, reverse GTTGGCCTCCTCTGTCTCAG.
Flow Cytometry
EBs were collected and dissociated into single cell suspensions
using 0.25% Trypsin/EDTA (Mediatech) or 2.4U/ml Dispase/
2.5mg/ml Collagenase D mixture. Cells were centrifuged and re-
suspended in 1% BSA-PBS then sterile filtered through an 80mm
sieve. Flow cytometry was performed with a Becton-Dickinson (B–
D) FACScan, and data were acquired using B–D CellQuest
software.
In Situ Hybridization
An in situ hybridization protocol for mouse embryos was
modified from [72] for use on EBs. Briefly, EBs were fixed in 4%
paraformaldehyde and serially dehydrated in methanol for
storage. EBs were re-hydrated, washed with PBS+0.1% Tween-
20 (PBT), and fixed with 4% paraformaldehyde (PFA)/0.2%
Glutaraldehyde. After washing, EBs were prehybridized for 1 hour
at 65uC followed by overnight hybridization with $1mg/mL of
probe. EBs were washed with 50% Formamide/5XSSC/1% SDS
at 65uC, treated with RNaseA, followed by washes with 50%
Formamide/2XSSC and Tris-buffered Saline+0.1% Tween-20
(TBST). EBs were then incubated overnight at 4uC in anti-DIG-
AP (1:1000) and 1% Boehringer blocking buffer. EBs were
washed extensively in TBST. Color was developed with BCIP/
NBT, and once color had developed, EBs were fixed with 4%
PFA. For sectioning, EBs were embedded in Tissue-Tek O.C.T.
compound and 12 mm cryosections were cut on a Leica
(CM3050) cryostat.
Immunohistochemistry
EB dissociation was performed as described above for flow
cytometery studies, cells were plated onto chamber slides and
incubated overnight at 37uC in differentiation medium to allow
cells to attach. Cells were washed briefly with PBS and fixed in 4%
PFA for 15 minutes. Blocking was carried out with 3% FBS-2%
BSA PBS for 1hr. Primary antibodies, anti-GFP, anti-Troponin T-
C (C-19), anti-Actin (C-11) (all from Santa Cruz Biotechnology,
Inc.), or anti-Sarcomeric Myosin, MF20 (Developmental Studies
Hybridoma Bank), were diluted in blocking solution to concen-
trations appropriate to the specific antibody and added to cells.
Cells were incubated overnight at 4uC, then washed with PBS and
blocked for 30 minutes at room temperature. Isotype appropriate
secondary antibodies, conjugated to Alexa FluorH 488 or Alexa
FluorH 555, (Invitrogen) were diluted and added to cells, followed
by an overnight incubation at 4uC. Finally, cells were washed with
PBS and cover slipped with Vectashield mounting medium
containing DAPI.
Microarray Analysis
Total RNA was isolated with Qiagen RNeasy Mini Kit and
used to probe Illumina expression array (MouseWG-
6_V2_0_R0_11278593) in triplicate for each of three heart-
inducing cell lines using Illumina BeadStudio version 3.4.0. The
raw Illumina data (9 arrays) was analyzed using Bioconductor
packages. The data was first normalized using LumiExpresso ()
function. The differentially expressed genes in each pair-wise
comparison were obtained using Limma ( ) R-package. For gene
ontology studies, Illumina probes were mapped to gene symbol
names using getAnnote.Illumina (‘‘MouseWG-6_V2_0_R0_
11278593_A.bz2’’) downloaded from Bioconductor website:
http://www.bioconductor.org/download.
Pathway and expression analysis was carried out using DAVID
Bioinformatics Resources 2008 sponsored by the National Institute
of Allergy and Infectious Diseases (NIAID), NIH, at http://david.
abcc.ncifcrf.gov/ [44,45]. This data is MIAME compliant and has
been deposited in NCBI’s Gene Expression Omnibus [73]. All
data is accessible through GEO Series accession number
GSE19564 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc
=GSE1956.
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